ClinicalTrials.gg
CompletedNCT07838363Updated Oct 16, 2026

Online Pain Management Programmes During the Covid-19 Pandemic

An observational study in Pain Management, sponsored by Walton Centre NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Walton Centre NHS Foundation Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 340 studies in COVID-19 with a site in United Kingdom — 17 open to participants now, 32 under way, 7 of them phase 3. COVID-19 · United Kingdom.

Enrollment
152nd of 167
30 · median 296
Started
2021
with 82 others
Observational
167 of 340
9 open now
Registered
340th of 340
by date

Among the 340 studies in COVID-19 with a site in United Kingdom, this one is the 152nd largest by enrollment of the 167 observational ones that give a count, is one of 83 that started in 2021, is one of 167 observational ones, and was the 340th registered.

COVID-19

7,992 studies on the registry are indexed under COVID-19; 466 are open to participants now.

Browse COVID-19 studies →

Open to participants now

17 of the 340 studies in COVID-19 with a site in United Kingdom are open now. Recruiting first, the newest first:

12 more — sign in →

All 17 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 356 COVID-19 studies recruiting now, 206 (58%) set no upper age limit and 83 (23%) stop at 75 or younger; 91 take children under 18; 135 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 340 studies in COVID-19 with a site in United Kingdom, or all of them as a file.
02

Study summary

A focus groups study facilitating an open discussion regarding the experience of being assessed for an online Pain Management Programme (OPMP) during the Covid-19 Pandemic. The aim is to gain an understanding of patient decision making processes in relation to whether to attend an OPMP. and determining patient experiences of attending a OPMP during this time period.

Read the detailed description

The primary research question is 'what are the experiences of patients being assessed for and attending an OPMP during the covid 19 pandemic'. Within this, there are numerous strands:

The investigators aim to gain an understanding of:

  • Participants' decision making processes in relation to acceptance of assessment and treatment for an OPMP in the context of the Covid 19 pandemic.
  • The influence of the global pandemic on these decision making processes
  • The perceived influence of the global pandemic on treatment engagement and outcomes themselves

The investigators also aim to:

  • Understand participants' reflections on their choice to engage in an OPMP having completed it (e.g. would they have made a different decision on reflection?).
  • To inform future practice should significant changes to service delivery occur. This could be both in short term (i.e. within the context of the current global pandemic), or longer term (i.e. as a result of other factors which could affect changes to treatment modality).
  • Inform our understanding of participants' experiences of the assessment process for attending an OPMP which may help to improve the investigator's assessment processes moving forwards.
  • To gain preliminary understandings (via questionnaire) of NHS Staff's experiences of changes to PMP delivery during the pandemic.
03

Conditions studied

  • Pain Management

Browse trials for

Keywords

  • Pain Management
  • Covid-19
  • Patient Experience
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients from the Walton Centre NHS Foundation Trust who have attended an OPMP during the Covid-19 pandemic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have attended a PMP assessment clinic and have been found clinically suitable for an online PMP at the Walton Centre
  • Consented to be contacted by the Walton Centre regarding potential involvement in research during the assessment process
  • Aged 18+
  • Able to provide written in English

Exclusion criteria

Exclusion Criteria:

  • Individuals who are unable to understand the study protocol or are unable to provide independently
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
30 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Determining patient decision making processes in relation to online PMP clinics

    Data will be collected via recordings of focus group discussions which will then be anonymously transcribed.

    Time frame: Between 1-10 years following completion of WCFT pain management programme, dependant on randomly selected patient.

07

Study locations

1 site
  • The Walton Centre NHS Foundation Trust
    Liverpool, Merseyside L97LJ, United Kingdom
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2021 to primary completion in Feb 2024, 27 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2026
First posted
Sep 24, 2026
StartActual
Oct 15, 2021
Primary completionActual
Feb 2, 2024
CompletionActual
Feb 2, 2024
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and description
1 update, last Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Minor edits only
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07838363
Lead sponsor
Walton Centre NHS Foundation Trust
Responsible party
Sponsor
First posted
Sep 24, 2026
Start date
Oct 15, 2021
Primary completion
Feb 2, 2024
Completion
Feb 2, 2024
Last update
Oct 16, 2026

Study contacts

Christian Ainsley
principal investigator · Walton Centre NHS Foundation Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion